학술논문
Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design
Document Type
Article
Author
Molina, J.-M.; Rubenstein, E.; Loze, B.; Bercot, B.; Goldwirt, L.; Assoumou, L.; Algarte-Genin, M.; Katlama, C.; Surgers, L.; Ouattara, M.; Costagliola, D.; Pialoux, G.; Bébéar, C.; Dupin, N.; Slama, L.; Pavie, J.; Duvivier, C.; Ghosn, J.; Gibowski, S.; Ollivier, M.; Aslan, A.; Pintado, C.; Delaugerre, C.; Ponscarme, D.; Dalle, E.; Chas, J.; Siguier, M.; Palich, R.; Valentin, M.-A.; Yazdanpanah, Y.; Lacombe, K.; Viard, J.-P.; Lourenco, J.; Rachline, A.; Detruchis, P.; Diemer, M.; Azemar, L.; Landowski, S.; Ometsguine, P.; Buisson, M.; Feliho, P.; Bachelard, A.; Phung, B.; Rioux, C.; Proux, C.; Le Gac, S.; Schneider, L.; Charmak, A.; Ktorza, N.; Seang, S.; Orriere, T.; Sellem, B.; Palacios, C.; Mebarki, S.
Source
In: The Lancet Infectious Diseases . (The Lancet Infectious Diseases, 2024)
Subject
Language
English
ISSN
14744457
14733099
14733099